Four-factor prothrombin complex concentrate use for on-label versus off-label indications: a retrospective cohort study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Link
https://link.springer.com/content/pdf/10.1007/s11239-022-02671-z.pdf
Reference19 articles.
1. Pandey S, Vyas GN (2012) Adverse effects of plasma transfusion. Transfusion 52:65S-79S. https://doi.org/10.1111/j.1537-2995.2012.03663.x
2. Sarode R, Milling TJ, Refaai MA et al (2013) Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation 128:1234–1243. https://doi.org/10.1161/CIRCULATIONAHA.113.002283
3. Frontera JA, Lewin JJ, Rabinstein AA et al (2016) Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the neurocritical care society and society of critical care medicine. Neurocrit Care 24:6–46. https://doi.org/10.1007/s12028-015-0222-x
4. Tomaselli GF, Mahaffey KW, Cuker A et al (2017) 2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants. J Am Coll Cardiol 70:3042–3067
5. Goldstein JN, Refaai MA, Milling TJ Jr et al (2015) Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. The Lancet 385:2077–2087
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-Term Safety of a Four-Factor Prothrombin Complex Concentrate (Kcentra®/Beriplex® P/N): An Updated Pharmacovigilance Review;Thrombosis and Haemostasis;2024-07-29
2. Ultra-Early Hemostatic Therapy for Acute Intracerebral Hemorrhage: An Updated Review;Cardiology in Review;2024-03-21
3. Utilization and safety of off-label prothrombin complex concentrate (4F-PCC) in a nonsurgical population;Blood Coagulation & Fibrinolysis;2024-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3